Leukoencephalopathies  >>  galantamine hydrobromide  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
galantamine hydrobromide / Generic mfg.
NCT00261573: A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia

Completed
3
593
US
galantamine hydrobromide
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Alzheimer Disease, Vascular Dementia
 
12/00
NCT00035191: A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

Completed
3
254
US
galantamine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Dementia, Vascular
 
09/03

Download Options